Keywords
Melanocytic hypertrophy
Quality of Life
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the quality of life and the impact of melasma on women with the disease. Methods: This is a qualitative-quantitative study in which 52 women over 18 years of age with melasma participated. The reflection of melasma in the social, emotional and professional sphere was evaluated by means of a virtual questionnaire, composed of: MELASQoL, DLQI-BRA, HADS Scale and Socio-Economic-Demographic Questionnaire. Students' t-test was applied to the results obtained to compare differences between the scores of the sample. This research was approved by the Ethics and Research with Human Beings Committee. Results: The research evidenced that: 67,3% of the participants did not perform dermatological medical follow-up; 78.8% used makeup to cover their macules; 82,6% and 86,5% felt depressed and less attractive to others; for 48,1% and 71,1% of them, melasma did not affect the performance of daily and leisure activities, as well as work and studies; 36,5% of them did not feel pleasure in leisure moments; and 30,8% did not enjoy the same things as before. Conclusion: We conclude that melasma affects the quality of life of women with this disease. Moreover, dissatisfaction with self-image, combined with daily stress, can worsen anxiety and depression.
References
ALI FR. Oral Tranexamic acid for the treatment of melasma. Clinical and Experimental Dermatology, 2019; 44(3): 347-349.
COSTA MC, et al. In vivo reflectance confocal microscopy in a typical case of melasma. An. Bras. Dermatol, 2012; 87(5): 782-784.
HANDEL AC, et al. Risk factors for facial melasma in women: a case-control study. British Journal of Dermatology, 2014; 171(3): 588-594.
IKINO JK, et al. Melasma and assessment of the quality of life in Brazilian women. An Bras Dermatol, 2015; 90(2): 196-200.
LAJEVARDI V, et al. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid tropical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst- blinded, randomized controlled trial with a short-term follow-up. Journal of Cosmetic Dermatology, 2017; 16(2): 235-242.
LU J, et al. Whitening Efficacy of Tranexamic Acid Cataplasm on Melasma in Chinese Women. Integrative Medicine International, 2017; 4(3-4):154–160.
MAGALHÃES GM, et al. Estudo duplo-cego e randomizado do peeling de ácido retinoico a 5% e 10% no tratamento do melasma: avaliação clínica e impacto na qualidade de vida. Surg Cosmet Dermatol, 2011; 3(1): 17-22.
MALIK F, et al. Combination of oral tranexamic acid with topical 3% tranexamic acid versus oral tranexamic acid with topical 20% azelaic acid in the treatment of melasma. Journal of the College of Physicians Surgeons Pakistan, 2019; 29(6): 502-504.
MARANZATTO CFP, et al. Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP). An Bras Dermatol, 2016; 91(4): 422-428.
MIOT LDB, et al. Physiopathology of melasma. An Bras Dermatol, 2009; 84(6): 623-635.
POLLO CF, et al. Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma). An Bras Dermatol, 2018a; 93(3): 391-6.
POLLO CF, et al. Evaluation instruments for quality of life related to melasma: an integrative review. Clinics, 2018b; 73: e65.
RODRIGUES M, et al. Interpretability of the modified melasma area and severity index (mMASI). JAMA Dermatol, 2016; 152(9): 1051-1052.
SHARMA R, et al. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clinical and Experimental Dermatology, 2017;42(7): 728-734.
TAWFIC OS, et al. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers in surgery and medicine, 2019; 51(1): 27-33.